Testing effectiveness (Phase 2)Ended earlyNCT03176277What this trial is testingONO-7475 in Patients With Acute LeukemiasWho this might be right forAcute LeukemiaMyelodysplastic Syndromes Ono Pharmaceutical Co., Ltd. 42
Not applicableStudy completedNCT05236296What this trial is testingEmotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot StudyWho this might be right forLeukemia, Acute University Health Network, Toronto 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769What this trial is testingStudy of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsWho this might be right forB-Cell Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 121
Not applicableEnded earlyNCT04858594What this trial is testingStudy of Periodontitis and Blood Stream Infection in AML Patients Receiving ChemotherapyWho this might be right forAcute Myeloid Leukemia Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT00386373What this trial is testingUse and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsWho this might be right forLeukemia M.D. Anderson Cancer Center 10
Early research (Phase 1)Looking for participantsNCT05188170What this trial is testingNiclosamide in Pediatric Patients With Relapsed and Refractory AMLWho this might be right forAcute Myeloid Leukemia (AML) Stanford University 16
Testing effectiveness (Phase 2)UnknownNCT04913922What this trial is testingRelatlimab With Nivolumab and 5-Azacytidine for the Treatment of AMLWho this might be right forAcute Myeloid Leukemia Ludwig-Maximilians - University of Munich 30
Testing effectiveness (Phase 2)Study completedNCT04230239What this trial is testingClinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaWho this might be right forNewly Diagnosed Secondary or High Risk AML PETHEMA Foundation 59
Testing effectiveness (Phase 2)Study completedNCT00055653What this trial is testingDonor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241What this trial is testingTesting Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia PatientsWho this might be right forAcute Myeloid Leukemia National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT03669172What this trial is testingEfectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute LeukemiaWho this might be right forACUTE LEUKEMIA Martín, José Luis Díez, M.D. 6
Not applicableUnknownNCT03419494What this trial is testingComparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL PatientsWho this might be right forAdult Acute Lymphoblastic Leukemia CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237What this trial is testingPhase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic LeukemiaWho this might be right forPhase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT02588456What this trial is testingPilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic LeukemiaWho this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia University of Pennsylvania 5
Large-scale testing (Phase 3)UnknownNCT03391739What this trial is testingCART-19 Cells For R/R B-ALLWho this might be right forRelapsed/Refractory B-cell ALL Fujian Medical University 20
Early research (Phase 1)Study completedNCT00093600What this trial is testingPKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Novartis Pharmaceuticals 69
Not applicableEnded earlyNCT01685411What this trial is testingBusulfan and Cyclophosphamide Followed By ALLO BMTWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01503541What this trial is testingS9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab OzogamicinWho this might be right forLeukemia SWOG Cancer Research Network 365
Not applicableLooking for participantsNCT06513273What this trial is testingObservational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)Who this might be right forAcute Myeloid LeukemiaAML, AdultAcute Myeloid Leukemia, Adult Gruppo Italiano Malattie EMatologiche dell'Adulto 397
Testing effectiveness (Phase 2)Looking for participantsNCT07228273What this trial is testingInduction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome OHSU Knight Cancer Institute 102